Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control. [electronic resource]
Producer: 20191018Description: 113-124 p. digitalISSN:- 1549-4713
- Accommodation, Ocular -- physiology
- Administration, Ophthalmic
- Atropine -- administration & dosage
- Axial Length, Eye
- Child
- Child, Preschool
- Disease Progression
- Dose-Response Relationship, Drug
- Double-Blind Method
- Female
- Humans
- Male
- Muscarinic Antagonists -- administration & dosage
- Myopia -- diagnosis
- Ophthalmic Solutions
- Quality of Life
- Refraction, Ocular -- physiology
- Surveys and Questionnaires
- Vision Tests
- Visual Acuity -- physiology
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.